扶桑薬品工業の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2021/01/07 | 2,650 | 2,735 | 2,648 | 2,735 | +85 | +3.2% | 14,100 |
2021/01/06 | 2,679 | 2,709 | 2,647 | 2,650 | +21 | +0.8% | 9,100 |
2021/01/05 | 2,739 | 2,739 | 2,629 | 2,629 | -81 | -3% | 13,800 |
2021/01/04 | 2,805 | 2,805 | 2,705 | 2,710 | -93 | -3.3% | 11,000 |
2020/12/30 | 2,849 | 2,849 | 2,764 | 2,803 | -41 | -1.4% | 8,700 |
2020/12/29 | 2,830 | 2,844 | 2,769 | 2,844 | +64 | +2.3% | 10,600 |
2020/12/28 | 2,876 | 2,876 | 2,753 | 2,780 | -67 | -2.4% | 15,200 |
2020/12/25 | 2,814 | 2,847 | 2,782 | 2,847 | +50 | +1.8% | 7,200 |
2020/12/24 | 2,869 | 2,869 | 2,776 | 2,797 | -32 | -1.1% | 13,900 |
2020/12/23 | 2,777 | 2,829 | 2,777 | 2,829 | +3 | +0.1% | 4,100 |
2020/12/22 | 2,845 | 2,853 | 2,751 | 2,826 | -19 | -0.7% | 7,100 |
2020/12/21 | 2,900 | 2,900 | 2,803 | 2,845 | -55 | -1.9% | 15,200 |
2020/12/18 | 2,841 | 2,926 | 2,815 | 2,900 | +84 | +3% | 15,100 |
2020/12/17 | 2,865 | 2,865 | 2,784 | 2,816 | +66 | +2.4% | 17,400 |
2020/12/16 | 2,865 | 2,879 | 2,746 | 2,750 | -112 | -3.9% | 20,100 |
2020/12/15 | 2,982 | 2,994 | 2,853 | 2,862 | -120 | -4% | 9,800 |
2020/12/14 | 2,971 | 3,020 | 2,956 | 2,982 | -18 | -0.6% | 20,400 |
2020/12/11 | 2,950 | 3,025 | 2,937 | 3,000 | +69 | +2.4% | 20,500 |
2020/12/10 | 2,900 | 2,939 | 2,897 | 2,931 | +23 | +0.8% | 4,700 |
2020/12/09 | 2,820 | 2,915 | 2,803 | 2,908 | +107 | +3.8% | 10,200 |
2020/12/08 | 2,777 | 2,812 | 2,753 | 2,801 | -19 | -0.7% | 6,400 |
2020/12/07 | 2,824 | 2,836 | 2,790 | 2,820 | -22 | -0.8% | 7,800 |
2020/12/04 | 2,850 | 2,883 | 2,811 | 2,842 | +25 | +0.9% | 8,900 |
2020/12/03 | 2,825 | 2,905 | 2,816 | 2,817 | -8 | -0.3% | 9,600 |
2020/12/02 | 2,807 | 2,888 | 2,804 | 2,825 | -32 | -1.1% | 15,900 |
2020/12/01 | 2,834 | 2,869 | 2,807 | 2,857 | +24 | +0.8% | 12,500 |
2020/11/30 | 2,924 | 2,924 | 2,800 | 2,833 | -81 | -2.8% | 14,300 |
2020/11/27 | 2,809 | 2,929 | 2,801 | 2,914 | +125 | +4.5% | 23,000 |
2020/11/26 | 2,727 | 2,795 | 2,721 | 2,789 | +62 | +2.3% | 10,200 |
2020/11/25 | 2,796 | 2,803 | 2,727 | 2,727 | -69 | -2.5% | 15,600 |
2020/11/24 | 2,899 | 2,899 | 2,763 | 2,796 | -33 | -1.2% | 9,400 |
2020/11/20 | 2,789 | 2,836 | 2,789 | 2,829 | +42 | +1.5% | 6,100 |
2020/11/19 | 2,789 | 2,833 | 2,720 | 2,787 | +21 | +0.8% | 11,000 |
2020/11/18 | 2,789 | 2,818 | 2,730 | 2,766 | -35 | -1.2% | 15,500 |
2020/11/17 | 2,857 | 2,872 | 2,797 | 2,801 | -103 | -3.5% | 14,300 |
2020/11/16 | 2,857 | 2,930 | 2,809 | 2,904 | +113 | +4% | 18,500 |
2020/11/13 | 2,854 | 2,883 | 2,780 | 2,791 | -98 | -3.4% | 13,700 |
2020/11/12 | 2,949 | 2,995 | 2,889 | 2,889 | -62 | -2.1% | 11,900 |
2020/11/11 | 3,050 | 3,050 | 2,875 | 2,951 | -99 | -3.2% | 30,800 |
2020/11/10 | 2,899 | 3,085 | 2,860 | 3,050 | +201 | +7.1% | 53,300 |
2020/11/09 | 2,900 | 2,900 | 2,748 | 2,849 | -60 | -2.1% | 13,900 |
2020/11/06 | 2,963 | 2,963 | 2,859 | 2,909 | -31 | -1.1% | 15,100 |
2020/11/05 | 2,831 | 2,940 | 2,831 | 2,940 | +176 | +6.4% | 33,400 |
2020/11/04 | 2,689 | 2,772 | 2,646 | 2,764 | +74 | +2.8% | 9,200 |
2020/11/02 | 2,643 | 2,737 | 2,573 | 2,690 | +54 | +2% | 8,100 |
2020/10/30 | 2,699 | 2,769 | 2,554 | 2,636 | -50 | -1.9% | 17,500 |
2020/10/29 | 2,607 | 2,700 | 2,607 | 2,686 | +39 | +1.5% | 7,200 |
2020/10/28 | 2,708 | 2,708 | 2,620 | 2,647 | -61 | -2.3% | 6,600 |
2020/10/27 | 2,728 | 2,728 | 2,692 | 2,708 | +30 | +1.1% | 10,000 |
2020/10/26 | 2,626 | 2,730 | 2,626 | 2,678 | +59 | +2.3% | 6,800 |
951~
1000
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「扶桑薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
扶桑薬 | 266,000円 | +8.3% | +98.1% | 3.08% | 8.74倍 | 0.60倍 |
|
人工腎臓用透析剤・補液が主軸の製薬中堅、透析剤は国内シェア5割。後発薬や製造受託も展開 |
ハートシード | 145,000円 | +154.1% | - | 0.00% | - | 7.10倍 |
|
慶応大学発ベンチャー。iPS細胞を使い独自の心筋再生用心筋球で重症心不全治療を目指す |
ミズホメディ | 163,000円 | -5.1% | -21.2% | 4.91% | 10.29倍 | 1.96倍 |
|
体外検査薬専業、感染症抗体、遺伝子検査機器、試薬開発。新型コロナで急成長、妊娠検査薬も |
セルソース | 111,700円 | -3.0% | -55.9% | 0.45% | 53.06倍 | 3.66倍 |
|
脂肪・血液由来の細胞加工受託など再生医療、変形性ひざ関節症向け軸に不妊治療関連も展開 |
ステムリム | 35,800円 | - | - | 0.00% | - | 2.91倍 |
|
大阪大学発バイオベンチャー。損傷細胞の活性化物質を動員、再生を促す「再生誘導医薬」を開発 |
市場注目の銘柄
チャート関連のコラム